Chemical ID
BRUCEANTIN
Ubiquitous
No
| Dosage | Reference |
|---|---|
| LD50=1.9-2.6 (ivn mus) | Merck 11th Edition |
Select a Results View:
Download these results as:
| Activity Sort descending | Dosage | Reference |
|---|---|---|
| Amebicide | IC50=0.035 uM | Duke, 1992 * |
| Antibacterial | IC9=12.5 ug/ml | Duke, 1992 * |
| Antifeedant | not available | Duke, 1992 * |
| Antigiardial | IC50=1.2 uM | Duke, 1992 * |
| Antileukemic | not available | Merck 11th Edition |
| Antimalarial | IC50=0.8 ng/ml | Duke, 1992 * |
| Antimelanomic | ED50=0.001 ug/ml | J. Ethnopharmacology, 32: 117. |
| Antisarcomic | ED50=0.0014 ug/ml | J. Ethnopharmacology, 32: 117. |
| Antiseptic | IC9=12.5 ug/ml | Duke, 1992 * |
| Antitubercular | IC9=12.5 ug/ml | Duke, 1992 * |
| Antitumor (Breast) | ED50=0.003 ug/ml | Cordell, G.A., Beecher, C.W.W., and Pezzuto, J.M. Can ethnopharmacology contribute to the development of new anticancer drugs? Journal of Ethnopharmacology, 32: 117-133, 1991. |
| Antitumor (Colon) | ED50=0.0074 ug/ml | Cordell, G.A., Beecher, C.W.W., and Pezzuto, J.M. Can ethnopharmacology contribute to the development of new anticancer drugs? Journal of Ethnopharmacology, 32: 117-133, 1991. |
| Cytotoxic | (KB) IC50=0.015 uM | Duke, 1992 * |
| Cytotoxic | 1 ppb | Duke, 1992 * |
| Mycobactericide | IC9=12.5 ug/ml | Duke, 1992 * |
| Pesticide | not available | Duke, 1992 * |
| Plasmodicide | IC50=0.0015 uM | Duke, 1992 * |
| Pyrogenic | 5.5 mg/sq m body, ivn hmn | Garnick, M. B., Blum, R. H., Canellos, G. P., Mayer, R. J., Parker, L., Skarin, A. T., Li, F. P., Henderson, I. C., Frei III, E. 1979. Phase I Trial of Bruceantin. Cancer Treat Rep, 63: 1929-1932. |
| Trypanocide | IC50=0.0015 uM | Duke, 1992 * |